High Court Won’t Review Federal Circuit Dismissal Of Patent Appeal

Mealey's (March 22, 2021, 1:46 PM EDT) -- WASHINGTON, D.C. — In its March 22 order list, the U.S. Supreme Court rejected a drug maker’s petition for certiorari in which it said it possessed standing to appeal a final written decision by the Patent Trial and Appeal Board that confirmed the patentability of a challenged method for treating relapsing-remitting multiple sclerosis (RR-MS)....